Navigation Links
American Society for Biochemistry and Molecular Biology Reacts to District Court Stem-Cell Ruling
Date:9/2/2010

BETHESDA, Md., Sept. 2 /PRNewswire-USNewswire/ -- The American Society for Biochemistry and Molecular Biology expressed its disapproval and disappointment this week in response to the Aug. 23 ruling in the U.S. District Court for the District of Columbia that granted a preliminary injunction barring federal funding of embryonic stem-cell research.

In a statement, the society said the decision, which came in response to a lawsuit filed by two adult stem-cell researchers, effectively halts human embryonic stem-cell research in the United States and "represents a crossroads in American scientific policy."

The society, which represents more than 12,000 scientists in both academia and industry worldwide, urged Congress to act swiftly to pass legislation that will restore federal funding to embryonic stem-cell researchers as to not further delay "potential medical cures for millions of sick Americans."

Meanwhile, the society said the ruling undercuts the "gold standard" peer-review process by allowing the merits of research projects to be determined by those on the judicial bench instead of those working at the laboratory bench:  "Funding of basic biomedical research is not a zero-sum game in which particular lines of research are supported at the expense of others; rather, the system has evolved so that each proposal is evaluated on both its merits and its future benefits for easing the burden of disease."

The peer-review process "is by nature competitive," the statement said, and has "resulted in new biomedical methodologies and technologies that continue to benefit society at large."

"Constraining funding to a limited subset of applications will doubtless limit discovery and hurt those who rely on those discoveries the most."

ASBMB underscored its support for existing guidelines developed and enforced by the National Institutes of Health and for U.S. House Resolution 4808, commonly known as the Stem Cell Research Advancement Act of 2009.  The society said the guidelines in H.R. 4808, which have been approved by a bipartisan coalition of lawmakers, "balance respect for ethical concerns and scientific advancement."

To read the full statement by ASBMB, visit http://www.asbmb.org/News.aspx?id=9348.

About the American Society for Biochemistry and Molecular Biology

The ASBMB is a nonprofit scientific and educational organization with more than 12,000 members worldwide. Most members teach and conduct research at colleges and universities. Others conduct research in various government laboratories, at nonprofit research institutions and in industry. The Society's student members attend undergraduate or graduate institutions.  For more information about ASBMB, visit www.asbmb.org.  


'/>"/>
SOURCE American Society for Biochemistry and Molecular Biology
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Access Pharmaceuticals Presents at American Chemical Society Annual Fall Meeting in Boston, MA
2. American Humane Association Announces Joy Mench, Ph.D., Joins the Scientific Advisory Committee of the American Humane Certified® Farm Animal Program
3. Bariatric Advantage to Attend American Society of Metabolic and Bariatric Surgery (ASMBS) Conference
4. Oramed Pharmaceuticals was Chosen to Present Two Abstracts at the 70th Scientific Sessions of the American Diabetes Association in Orlando, FL, June 25-29, 2010
5. Genomic Health Presents Six New Studies Including Four Oral Presentations in Breast, Colon and Renal Cancers at American Society of Clinical Oncology (ASCO) Annual Meeting
6. New Cancer Treatments and Combination Therapies Presented by Leading Experts from the John Theurer Cancer Center at the American Society of Clinical Oncology Annual Meeting
7. NeoStem Selected to Present at American Society for Apheresis
8. Simbionix to Reveal Two new Products at the Upcoming American Urology Association (AUA) Annual Meeting
9. Dendreon Announces Presentation of PROVENGE Data at the American Society of Clinical Oncology Annual Meeting
10. Nexavar Data to be Presented at 46th American Society of Clinical Oncology Annual Meeting
11. NewLink Genetics to Present Phase 2 Data on HyperAcute(R)-Pancreas Immunotherapy at the American Society of Clinical Oncology Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , ... June 23, 2016 , ... ... release of its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering ... retention in this eBook by providing practical tips, tools, and strategies for clinical ...
(Date:6/23/2016)... /PRNewswire/ - FACIT has announced the creation of ... company, Propellon Therapeutics Inc. ("Propellon" or "the Company"), ... portfolio of first-in-class WDR5 inhibitors for the treatment ... represent an exciting class of therapies, possessing the ... cancer patients. Substantial advances have been achieved with ...
(Date:6/23/2016)... Lawrence, MA (PRWEB) , ... June 23, 2016 ... ... the Peel Plate® YM (Yeast and Mold) microbial test has received AOAC Research ... test platform of microbial tests introduced last year,” stated Bob Salter, Vice President ...
(Date:6/23/2016)... , June 23, 2016   EpiBiome , ... secured $1 million in debt financing from Silicon Valley ... up automation and to advance its drug development efforts, ... new facility. "SVB has been an incredible ... the services a traditional bank would provide," said Dr. ...
Breaking Biology Technology:
(Date:6/2/2016)... , June 2, 2016 ... Manned Platforms, Unmanned Systems, Physical Infrastructure, Support & Other ... provider visiongain offers comprehensive analysis of the ... this market will generate revenues of $17.98 billion in ... acquired DVTEL Inc, a leader in software and hardware ...
(Date:5/20/2016)... , May 20, 2016  VoiceIt is ... partnership with VoicePass. By working together, ... experience.  Because VoiceIt and VoicePass take slightly different ... engines increases both security and usability. ... excitement about this new partnership. "This ...
(Date:5/9/2016)... -- Elevay is currently known as the ... high net worth professionals seeking travel for work   ... there is still no substitute for a face-to-face meeting. ... deal with a firm handshake. This is why wealthy ... citizenship via investment programs like those offered by the ...
Breaking Biology News(10 mins):